Udenyca Injection, Solution
Product Images NDC 70114-130

100 FDA label images from Coherus Oncology, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 100 technical images submitted to the FDA as part of the official labeling for Udenyca (NDC 70114-130). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Coherus Oncology, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Image Of Udenyca Before Use (Udenyca 01)

Image Of Udenyca Before Use (Udenyca 01)
A labeled diagram illustration of a prefilled syringe showing parts including the needle cap, needle, needle safety guard (unactivated), syringe body, label, inspection window, finger grips, plunger, and plunger head. This schematic aids in identifying components of the injection device.*
FDA Label Image

Image Of Udenyca After Use (Udenyca 02)

Image Of Udenyca After Use (Udenyca 02)
An instructional diagram labeled Figure 2 showing a partially disassembled syringe with a needle safety guard activated, indicating a safety feature to cover the needle after use.*
FDA Label Image

Image Of Storage (instructions for use)

Image Of Storage (instructions for use)
An illustration showing a box labeled UDENYCA (pegfilgrastim-cbqv) next to an open refrigerator, with an arrow pointing from the box toward the refrigerator interior shelves, depicting storage of the product in a refrigerator.*
FDA Label Image

Image Of Removal From Storage (instructions for use)

Image Of Removal From Storage (instructions for use)
An instructional diagram showing a hand holding a UDENYCA (pegfilgrastim-cbqv) injection solution cartridge, with an arrow indicating insertion into a device. The image also shows a close-up of the cartridge's expiration date location marked as 'EXP: 2019 JAN.'*
FDA Label Image

Image Of Opening Udenyca (instructions for use)

Image Of Opening Udenyca (instructions for use)
An instructional illustration showing hands holding and removing the outer packaging of a UDENYCA pegfilgrastim-cbqv injection, solution 6 mg/.6 mL, to reveal the prefilled syringe inside. The image focuses on proper handling of the product carton or tray.*
FDA Label Image

Image Of Time To Reach Room Temp (instructions for use)

Image Of Time To Reach Room Temp (instructions for use)
An instructional diagram showing a stopwatch set at 30 minutes with an arrow curving clockwise, indicating a 30-minute time interval.*
FDA Label Image

Image Of Gathering Supplies (instructions for use)

Image Of Gathering Supplies (instructions for use)
An instructional illustration showing four items: a sharps disposal container with a label reading 'Sharps Container,' an alcohol wipe packet, a cotton ball, and an adhesive bandage. These are likely depicted as supplies for injection site care or disposal.*
FDA Label Image

Image Of Proper Hand Washing (instructions for use)

Image Of Proper Hand Washing (instructions for use)
An instructional illustration showing handwashing technique with soap and running water. One hand is rubbing the back of the other hand to demonstrate thorough cleaning, typical in hygiene or injection preparation instructions.*
FDA Label Image

Image Of Removal Of Udenyca From Tray (instructions of use)

Image Of Removal Of Udenyca From Tray (instructions of use)
Illustration showing the UDENYCA (pegfilgrastim-cbqv) prefilled syringe within its packaging and a hand holding the syringe, possibly demonstrating removal or preparation steps. The syringe is designed for subcutaneous injection, as indicated by the product data.*
FDA Label Image

Image Of Visual Inspection (instructions for use)

Image Of Visual Inspection (instructions for use)
An instructional illustration showing a hand holding an injection pen labeled UDENYCA. The diagram points out an labeled 'Inspection Window' on the pen, highlighting where to visually check the medication inside the device prior to injection.*
FDA Label Image

Image Of Injection Site Selection (instructions for use)

Image Of Injection Site Selection (instructions for use)
An instructional diagram showing recommended subcutaneous injection sites for UDENYCA (pegfilgrastim-cbqv). Front and back human body outlines highlight injection areas: abdomen, thigh, upper outer buttock, and back of upper arm.*
FDA Label Image

Image Of Cleaning Injection Site (instructions for use)

Image Of Cleaning Injection Site (instructions for use)
An instructional illustration showing a hand holding a piece of cloth or wipe, cleaning a circular area on a surface. This figure appears to demonstrate a preparation step, likely related to sanitation or sterilization before an injection procedure.*
FDA Label Image

Image Of Removal Of Needle Cap (instructions for use)

Image Of Removal Of Needle Cap (instructions for use)
An instructional illustration showing the removal of a syringe plunger from a syringe barrel. The first frame depicts hands holding the syringe by the barrel with the plunger partially depressed. The second frame shows the plunger being pulled straight out from the syringe barrel, indicated by an upward arrow.*
FDA Label Image

Image Of Position Of Fingers (instructions for use)

Image Of Position Of Fingers (instructions for use)
An instructional illustration showing a hand holding a prefilled syringe labeled UDENYCA (pegfilgrastim-cbqv) 6 mg/0.6 mL for subcutaneous injection. The image demonstrates proper grip and syringe positioning for administration.*
FDA Label Image

Image Of Pinching Skin Of Injection Site (instructions for use)

Image Of Pinching Skin Of Injection Site (instructions for use)
An instructional illustration labeled Figure 14 showing a hand pinching the skin on an arm, likely demonstrating the proper technique for preparing or administering a subcutaneous injection.*
FDA Label Image

Image Of Proper Needle Insertion (instructions for use)

Image Of Proper Needle Insertion (instructions for use)
An instructional illustration showing the correct technique for subcutaneous injection. It depicts a hand holding a syringe at a 45-degree angle to the skin, with another hand stabilizing the injection site. The image includes angle indicators showing 90 degrees and 45 degrees to guide proper injection angle.*
FDA Label Image

Image Of Injection Finger Positioning (instructions for use)

Image Of Injection Finger Positioning (instructions for use)
An instructional illustration showing hands preparing a subcutaneous injection using a syringe with an attached needle, demonstrating the technique for UDENYCA (pegfilgrastim-cbqv) injection, solution, 6 mg/0.6 mL.*
FDA Label Image

Image Of Plunger Push (instructions for use)

Image Of Plunger Push (instructions for use)
An instructional illustration showing how to remove or prepare a subcutaneous injection using a prefilled syringe. The figure focuses on the hand holding the syringe, with a close-up inset highlighting the syringe tip and cap, indicating the direction to pull or twist to remove the protective cap before administration.*
FDA Label Image

Image Of Needle Retraction (instructions for use)

Image Of Needle Retraction (instructions for use)
Illustration showing two steps of preparing an injection from a prefilled syringe, including removing a cap and pulling back on the plunger, likely for UDENYCA pegfilgrastim-cbqv 6 mg/.6 mL subcutaneous injection.*
FDA Label Image

Image Of Disposal (instructions for use)

Image Of Disposal (instructions for use)
An instructional illustration showing a hand safely disposing of a used prefilled injection syringe labeled UDENYCA pegfilgrastim-cbqv into a labeled sharps container, indicating proper disposal of the subcutaneous injection device.*
FDA Label Image

Image Of Before Use And After Use (AI instructions for use)

Image Of Before Use And After Use (AI instructions for use)
An instructional diagram of the UDENYCA 6 mg/.6 mL injection autoinjector by Coherus Oncology, Inc. It labels parts of the device before use including the clear cap, gray needle guard, viewing window, gray plunger, autoinjector body, and product label with the expiration date on the other side. After use, the orange indicator fills the viewing window to show the injection is complete.*
FDA Label Image

Image Of Removing Udenyca From Refrigeration (AI instructions for use)

Image Of Removing Udenyca From Refrigeration (AI instructions for use)
An instructional illustration showing a hand placing a medication box into a refrigerator. A clock icon indicates a 30-minute wait time, suggesting the medication should be refrigerated for 30 minutes before use.*
FDA Label Image

Image Of Udenyca Autoinjector Status, Sharps Container And Hand Washing (AI instructions for use)

Image Of Udenyca Autoinjector Status, Sharps Container And Hand Washing (AI instructions for use)
Step 2 of an instructional diagram for UDENYCA (pegfilgrastim-cbqv) subcutaneous injection shows checking the expiration date on the prefilled syringe label, disposing of used materials in a waste bin, and washing hands under running water afterward.*
FDA Label Image

Image Of Choosing Injection Site (AI instructions for use)

Image Of Choosing Injection Site (AI instructions for use)
An instructional illustration showing recommended injection sites for UDENYCA (pegfilgrastim-cbqv) 6 mg/0.6 mL subcutaneous injection. It depicts two human figures: one labeled 'Self or Caregiver' highlighting the abdomen and thigh as injection areas, and the other labeled 'Caregiver only' showing the back of the upper arm and buttock as injection sites.*
FDA Label Image

Image Of Choosing Injection Site (AI instructions for use)

Image Of Choosing Injection Site (AI instructions for use)
An instructional illustration showing a hand applying a small adhesive patch or bandage to a skin surface, likely indicating post-injection care for a subcutaneous injection site.*
FDA Label Image

Image Of Checking Veiwing Window (AI instructions for use)

Image Of Checking Veiwing Window (AI instructions for use)
Illustration showing the inspection window of a UDENYCA prefilled syringe. The magnified inset focuses on the syringe's medicine reservoir, highlighting the visibility of the solution level inside the device before administration.*
FDA Label Image

Image Of Of Removing The Cap Of The Autoinjector (AI instructions for use)

Image Of Of Removing The Cap Of The Autoinjector (AI instructions for use)
An instructional illustration showing two hands using a medical injection device. One hand holds the injection pen, while the other hand is removing or attaching a small cap or cover from the top of the device, indicated by green vertical arrows showing the motion direction.*
FDA Label Image

Image Of Of How To Properly Hold The Autoinjector (AI instructions for use)

Image Of Of How To Properly Hold The Autoinjector (AI instructions for use)
An instructional diagram showing a hand holding a prefilled injection syringe vertically at a 90-degree angle, likely demonstrating correct positioning for subcutaneous administration of an injection.*
FDA Label Image

Image Of Press And First Click (AI instructions of use)

Image Of Press And First Click (AI instructions of use)
Instructional illustration showing a hand holding a UDENYCA injection device vertically, pressing down to the first 'click'. A green arrow points downward indicating the injection step direction.*
FDA Label Image

Image Of After Second Click (AI instructions for use)

Image Of After Second Click (AI instructions for use)
An instructional illustration for using UDENYCA (pegfilgrastim-cbqv) injection, showing a hand holding the injection device vertically after the second "Click," with a zoomed inset highlighting the orange indicator on the device. The text advises to count to 5 after the second click before proceeding.*
FDA Label Image

Image Of Proper Pull Away Of Udenyca Autoinjector Post Injection (AI instructions for use)

Image Of Proper Pull Away Of Udenyca Autoinjector Post Injection (AI instructions for use)
Instructional illustration showing a hand holding a prefilled syringe with an orange visible inside the barrel. A green upward arrow indicates the action of pulling or lifting the syringe upward, likely as part of the injection preparation or administration process.*
FDA Label Image

Image Of Disposal Of Used Udenyca Autoinjector (AI instructions for use)

Image Of Disposal Of Used Udenyca Autoinjector (AI instructions for use)
An instructional illustration showing a hand disposing of a used prefilled syringe into a sharps disposal container. The image emphasizes safe disposal of injection equipment, relevant to subcutaneous injections like UDENYCA (pegfilgrastim-cbqv) 6 mg/0.6 mL.*
FDA Label Image

Image 1 (UDENYCA ONBODY injector)

Image 1 (UDENYCA ONBODY injector)
An instructional diagram labeling parts of an injection syringe for UDENYCA (pegfilgrastim-cbqv). The syringe components identified include the plunger rod, syringe barrel, label with expiration date, medicine inside the barrel, and gray needle cap, illustrating the structure of the subcutaneous injection device.*
FDA Label Image

Image 2 (UDENYCA ONBODY injector)

Image 2 (UDENYCA ONBODY injector)
Illustration showing front and back views of an injection device for UDENYCA (pegfilgrastim-cbqv) 6 mg/0.6 mL subcutaneous injection. The front view includes labeled features: fill indicator, pull tabs, metal medicine port (fill here), status light, and green fill guide. The back view shows an automatic needle opening with warnings not to fill near it and adhesive backing.*
FDA Label Image

Image 3 (UDENYCA ONBODY injector)

Image 3 (UDENYCA ONBODY injector)
Illustration showing preferred injection sites for UDENYCA (pegfilgrastim-cbqv) on a human body. The highlighted areas for subcutaneous injection include the back of the upper arms (triceps area) and the abdomen, both front and side views are shown.*
FDA Label Image

Image 4 (UDENYCA ONBODY injector)

Image 4 (UDENYCA ONBODY injector)
An instructional diagram showing a circular injection device for UDENYCA (pegfilgrastim-cbqv) 6 mg/0.6 mL subcutaneous injection, with a visible green clip and a label marked 'FULL' and 'EMPTY.' Above the device is a small alcohol wipe packet, indicating preparation or cleaning before use.*
FDA Label Image

Image 5 (UDENYCA ONBODY injector)

Image 5 (UDENYCA ONBODY injector)
An instructional illustration showing two hands holding a blister pack containing an injection device. One hand is pulling a tab with a blue arrow and the other hand is gripping the pack, indicating the action to remove or activate part of the packaging or device.*
FDA Label Image

Image 6 (UDENYCA ONBODY injector)

Image 6 (UDENYCA ONBODY injector)
An instructional illustration showing a hand gripping and pulling on a device labeled 'Grab here' to remove a safety cap or cover from a syringe, indicating the proper way to prepare the injection. The syringe is held horizontally, with arrows pointing to the grip area.*
FDA Label Image

Image 7 (UDENYCA ONBODY injector)

Image 7 (UDENYCA ONBODY injector)
An instructional diagram of a prefilled syringe for UDENYCA (pegfilgrastim-cbqv) injection, 6 mg/0.6 mL. The labeled parts include the plunger rod, syringe barrel with a label showing lot and expiration date, medicine inside the barrel, and a gray needle cap.*
FDA Label Image

Image 8 (UDENYCA ONBODY injector)

Image 8 (UDENYCA ONBODY injector)
Illustration showing instructions for removing air bubbles from a syringe before using an on-body injector. Text advises removing the gray needle cap, tapping the syringe to move air bubbles to the top, slowly pushing air out without expelling medicine, noting a small droplet at the needle tip is normal, and not recapping the syringe. The image includes a hand holding a syringe with an arrow indicating the direction to push air out.*
FDA Label Image

Image 9 (UDENYCA ONBODY injector)

Image 9 (UDENYCA ONBODY injector)
An instructional diagram showing hands holding a UDENYCA injection device in its packaging. A syringe is positioned at a 90-degree angle to insert into a green part of the device, highlighting the step to access the medication before administration.*
FDA Label Image

Image 10 (UDENYCA ONBODY injector)

Image 10 (UDENYCA ONBODY injector)
An instructional diagram showing hands holding the UDENYCA prefilled injector. A syringe is being activated by pressing down, indicated by a blue arrow. The illustration highlights a green status indicator and shows an 'OKAY LIGHT' symbol with accompanying sound waves signaling a beep, indicating proper activation of the injection device.*
FDA Label Image

Image 11 (UDENYCA ONBODY injector)

Image 11 (UDENYCA ONBODY injector)
An illustration showing a yellow indicator labeled with 'FULL' and 'EMPTY' to indicate fill status. The indicator is embedded within a device shape, likely a pre-filled injection device, showing the fluid level in the viewing window as part of the administration process for the injection solution.*
FDA Label Image

Image 12 (UDENYCA ONBODY injector)

Image 12 (UDENYCA ONBODY injector)
An instructional illustration showing how to remove a safety clip from a prefilled injection device. The left side depicts lifting the device upward from its tray. The right side instructs to squeeze and lift the green safety clip after confirming the 'OKAY LIGHT' indicator. The steps demonstrate preparation for administering a subcutaneous injection.*
FDA Label Image

Image 13 (UDENYCA ONBODY injector)

Image 13 (UDENYCA ONBODY injector)
An instructional illustration showing the steps for using an injection device. It depicts hands holding the device while unpeeling tab 1 and tab 2, with an indicator labeled 'OKAY LIGHT' and a note on the automatic needle opening mechanism. The image guides proper preparation before injection.*
FDA Label Image

Image 14 (UDENYCA ONBODY injector)

Image 14 (UDENYCA ONBODY injector)
An instructional illustration showing a hand holding a white, rectangular injection device with rounded edges, likely a prefilled autoinjector for subcutaneous administration. The device has a small circular button or indicator near the top.*
FDA Label Image

Image 15 (UDENYCA ONBODY injector)

Image 15 (UDENYCA ONBODY injector)
Instructional illustration showing proper application of an on-body injector device onto a person's upper arm. The image features a hand pressing the adhesive part of the device firmly to the skin, with text emphasizing pressing firmly to ensure adhesion, avoiding folds or wrinkles, and not using other materials that could cover indicators or compress the device.*
FDA Label Image

Image 16 (UDENYCA ONBODY injector)

Image 16 (UDENYCA ONBODY injector)
Illustration showing a person applying or activating a small adhesive patch device on the upper arm. The device has a visible label or screen on top and is intended for subcutaneous use, likely related to self-administration of a medication injection.*
FDA Label Image

Image 17 (UDENYCA ONBODY injector)

Image 17 (UDENYCA ONBODY injector)
An instructional illustration showing a person's abdomen with a wearable injection device attached. A hand is shown pressing or activating the device, demonstrating its subcutaneous application method for delivering medication, relevant to pegfilgrastim-cbqv injection.*
FDA Label Image

Image 18 (UDENYCA ONBODY injector)

Image 18 (UDENYCA ONBODY injector)
A warning text panel with a red stop sign icon. The text advises to check the quality of adhesion before sending the patient home.*
FDA Label Image

Image 19 (UDENYCA ONBODY injector)

Image 19 (UDENYCA ONBODY injector)
An instructional illustration showing two examples of incorrect applications of an adhesive on a device, labeled with red X marks. The left example depicts wrinkled adhesive, and the right example shows folded adhesive, both with a visual indicator labeled FULL and EMPTY.*
FDA Label Image

Image 20 (UDENYCA ONBODY injector)

Image 20 (UDENYCA ONBODY injector)
An instructional diagram showing what to do if a device emits a beeping sound and its status light is flashing red. It highlights an incorrect condition with an error light illuminated on the device and indicates the presence of beeping sounds.*
FDA Label Image

Image 21 (UDENYCA ONBODY injector)

Image 21 (UDENYCA ONBODY injector)
An illustration showing what to do if the adhesive of an on-body injector becomes saturated with fluid or if the injector is dripping. It features two images of the device, each marked with a red X: one showing saturated adhesive, the other showing dripping fluid from the injector.*
FDA Label Image

Image 1 (UDENYCA ONBODY injector)

Image 1 (UDENYCA ONBODY injector)
An instructional form illustrating an on-body injector device with a window indicating 'Full' or 'Empty.' The form includes fields for recording the day and time the injector was applied and when injection delivery will start, as well as spaces for healthcare provider name, contact number, and on-body injector lot number. The image relates to the administration tracking of UDENYCA injection.*
FDA Label Image

Image 2 (UDENYCA ONBODY injector)

Image 2 (UDENYCA ONBODY injector)
An instructional diagram of a medical device showing the status light and fill indicator. The status light is highlighted as a small green light, with illustrations of its different states in green and red. The fill indicator is shown as a yellow rectangular label with markings for FULL and EMPTY, with arrows pointing to each state on separate examples.*
FDA Label Image

Image 3 (UDENYCA ONBODY injector)

Image 3 (UDENYCA ONBODY injector)
An instructional illustration depicting a device attached to the abdomen skin, with a label showing 'OKAY LIGHT' and a clock icon indicating 27 hours. The image suggests a timing or status indicator related to the device's use or function on the skin area.*
FDA Label Image

Image 4 (UDENYCA ONBODY injector)

Image 4 (UDENYCA ONBODY injector)
Illustration showing the back view of a person's upper body with a medical adhesive patch applied to the upper arm, demonstrating a possible site for subcutaneous injection, relevant for the administration of UDENYCA (pegfilgrastim-cbqv) injection solution.*
FDA Label Image

Image 5 (UDENYCA ONBODY injector)

Image 5 (UDENYCA ONBODY injector)
An instructional illustration showing a UDENYCA injection device applied to the skin. The image indicates a green 'OKAY LIGHT' symbol and a 5-minute timer, suggesting the device should remain in place for this duration during subcutaneous administration of pegfilgrastim-cbqv.*
FDA Label Image

Iimage 6 (UDENYCA ONBODY injector)

Iimage 6 (UDENYCA ONBODY injector)
Instructional illustration for UDENYCA (pegfilgrastim-cbqv) on-body injector use. It warns against removing the injector if the status light is flashing green and advises monitoring for leaks during the 5-minute dose delivery. Two diagrams show incorrect conditions: noticeably wet adhesive and dripping fluid from the injector.*
FDA Label Image

Image 7 (UDENYCA ONBODY injector)

Image 7 (UDENYCA ONBODY injector)
An instructional diagram illustrating the status lights of an on-body injector used with UDENYCA (pegfilgrastim-cbqv) injection. The image shows a green finish light indicating dose completion and an error red flashing light with beeping signifying a malfunction, advising to contact a healthcare provider for replacement.*
FDA Label Image

Image 8 (UDENYCA ONBODY injector)

Image 8 (UDENYCA ONBODY injector)
An instructional illustration showing a person's hand peeling off the adhesive backing of a UDENYCA (pegfilgrastim-cbqv) injection, solution, subcutaneous delivery device labeled with 'Full' and 'Empty' indicators. The device is being applied to the skin, demonstrating proper preparation before use.*
FDA Label Image

Image 9 (UDENYCA ONBODY injector)

Image 9 (UDENYCA ONBODY injector)
An instructional graphic featuring a red stop sign followed by the text "Check to see if your on-body injector is empty." This image serves as a reminder for users to verify the status of their injection device.*
FDA Label Image

Image 10 (UDENYCA ONBODY injector)

Image 10 (UDENYCA ONBODY injector)
An illustration of a hand holding a small medical injector device with a window that indicates medication volume. The window shows labels "FULL" and "EMPTY" with an arrow pointing to the "EMPTY" mark, highlighting the device's dose indicator status.*
FDA Label Image

Image 11 (UDENYCA ONBODY injector)

Image 11 (UDENYCA ONBODY injector)
Text panel listing instructions related to the status light on an on-body injector. It explains that a solid green or off status light means delivery is complete; if the injector has leaked or the status light is red, users should contact their healthcare provider as a replacement dose may be needed.*
FDA Label Image

Image 12 (UDENYCA ONBODY injector)

Image 12 (UDENYCA ONBODY injector)
An instructional illustration showing a hand disposing of a UDENYCA prefilled injection device into a red sharps disposal container, demonstrating safe injection pen disposal.*
FDA Label Image

Image 13 (UDENYCA ONBODY injector)

Image 13 (UDENYCA ONBODY injector)
An instructional illustration showing a close-up of a device with a yellow indicator label marked FULL and EMPTY. A blue arrow points to the indicator, which is positioned at EMPTY, signifying a correct status.*
FDA Label Image

Image 14 (UDENYCA ONBODY injector)

Image 14 (UDENYCA ONBODY injector)
A text panel titled with a warning about actions to take if a beeping sound is heard or a status light is flashing red, possibly related to a device or medication administration equipment.*
FDA Label Image

Image 15 (UDENYCA ONBODY injector)

Image 15 (UDENYCA ONBODY injector)
Illustration showing an error indicator for a medical injection device. It depicts a red flashing error light and accompanying beeps indicating an incorrect condition, with a close-up of a device status window marked with empty and full levels.*
FDA Label Image

Image 16 (UDENYCA ONBODY injector)

Image 16 (UDENYCA ONBODY injector)
Text panel heading in red asking, 'What do I do if the on-body injector comes off before the full dose is delivered?'. The panel likely provides instructions or information related to the usage of an on-body injector device for UDENYCA injection solution.*
FDA Label Image

Image 17 (UDENYCA ONBODY injector)

Image 17 (UDENYCA ONBODY injector)
This text panel addresses a question about the presence of blood at the application site after removing the on-body injector. The text is in red font on a white background and relates to user information or guidance for the UDENYCA injection.*
FDA Label Image

Image 18 (UDENYCA ONBODY injector)

Image 18 (UDENYCA ONBODY injector)
Text panel posing a question about site reactions, specifically asking 'What if my application site is red or tender after on-body injector removal?' indicating a frequently asked question or patient counseling point related to injection site reactions.*
FDA Label Image

Image A (UDENYCA ONBODY injector)

Image A (UDENYCA ONBODY injector)
A data table summarizing electromagnetic emissions testing of a delivery system. It lists two emissions tests (IEC 60601-1-2/CISPR 11 and ETSI EN 301 489-1, EN 301 489-17, EN 55032) with their respective frequency ranges and compliance levels indicating suitability for home healthcare environments.*
FDA Label Image

Image B (UDENYCA ONBODY injector)

Image B (UDENYCA ONBODY injector)
A data table detailing the electromagnetic immunity testing of the delivery system for UDENYCA (pegfilgrastim-cbqv) injection. It lists various immunity tests, IEC test levels, and corresponding compliance levels for electrostatic discharge, radiated RF EM fields, rated power frequency magnetic fields, and proximity magnetic fields.*
FDA Label Image

Image C (UDENYCA ONBODY injector)

Image C (UDENYCA ONBODY injector)
A data table listing test frequencies in MHz, corresponding band ranges, related communication services, modulation types, and immunity test levels measured in V/m. Services include TETRA, GMRS, FRS, LTE bands, GSM, CDMA, Bluetooth, WLAN, RFID, and others with modulation types mostly pulse modulation and FM. Immunity test levels range from 9 to 28 V/m.*
FDA Label Image

Image 1 (UDENYCA ONBODY injector)

FDA Label Image

Image 2 (UDENYCA ONBODY injector)

FDA Label Image

Image 3 (UDENYCA ONBODY injector)

FDA Label Image

Image 4 (UDENYCA ONBODY injector)

Image 4 (UDENYCA ONBODY injector)
An image showing two adjacent boxes labeled "LOT" and "SN," typically used for entering lot numbers and serial numbers on pharmaceutical packaging or documentation. No additional product information or text is visible.*
FDA Label Image

Image 4 (UDENYCA ONBODY injector)

Image 4 (UDENYCA ONBODY injector)
UDENYCA 6 mg/0.6 mL injection, solution for subcutaneous use, in a prefilled syringe. The label shows the proprietary name, active ingredient pegfilgrastim-cbqv, and the labeler Coherus Oncology, Inc. Packaging includes a single syringe with associated product information printed on it.*
FDA Label Image

Image 6 (UDENYCA ONBODY injector)

FDA Label Image

Image 7 (UDENYCA ONBODY injector)

FDA Label Image

Image 8 (UDENYCA ONBODY injector)

FDA Label Image

Image 9 (UDENYCA ONBODY injector)

FDA Label Image

Image 10 (UDENYCA ONBODY injector)

FDA Label Image

Image 11 (UDENYCA ONBODY injector)

FDA Label Image

Image 12 (UDENYCA ONBODY injector)

Image 12 (UDENYCA ONBODY injector)
Packet of UDENYCA pegfilgrastim-cbqv injection, solution 6 mg in 0.6 mL for subcutaneous use. The single-dose packet is labeled with the proprietary name UDENYCA and the labeler Coherus Oncology, Inc.*
FDA Label Image

Image 13 (UDENYCA ONBODY injector)

FDA Label Image

Image 14 (UDENYCA ONBODY injector)

FDA Label Image

Image 15 (UDENYCA ONBODY injector)

FDA Label Image

Image 16 (UDENYCA ONBODY injector)

FDA Label Image

Image 17 (UDENYCA ONBODY injector)

FDA Label Image

Image 18 (UDENYCA ONBODY injector)

FDA Label Image

Image 19 (UDENYCA ONBODY injector)

FDA Label Image

Image 20 (UDENYCA ONBODY injector)

FDA Label Image

Image 21 (UDENYCA ONBODY injector)

FDA Label Image

Image 22 (UDENYCA ONBODY injector)

Image 22 (UDENYCA ONBODY injector)
An illustration showing a syringe with a needle attached and a protective cap on the needle. The image likely depicts the components of an injection device used for subcutaneous administration.*
FDA Label Image

Image 23 (UDENYCA ONBODY injector)

Image 23 (UDENYCA ONBODY injector)
UDENYCA 6 mg/0.6 mL injection, solution for subcutaneous use. The image shows a single-dose prefilled syringe cartridge with a clear body and rounded rectangular shape. The syringe is designed for administration of pegfilgrastim-cbqv and labeled by Coherus Oncology, Inc.*
FDA Label Image

Image Of Carton Label (principal panel)

Image Of Carton Label (principal panel)
UDENYCA 6 mg/0.6 mL injection, solution for subcutaneous use, containing pegfilgrastim-cbqv. The label highlights a 6 mg in 0.6 mL single-dose prefilled syringe of sterile solution with no preservative. It is a pegylated recombinant methionyl human granulocyte colony-stimulating factor derived from E. coli. The labeler is Coherus Oncology, Inc.*
FDA Label Image

Image Of Ai Carton Label (principal panel)

Image Of Ai Carton Label (principal panel)
UDENYCA 6 mg/0.6 mL injection, solution in a single-dose prefilled autoinjector for subcutaneous use. The label shows the product name, generic name pegfilgrastim-cbqv, strength, and route. It is a sterile solution with no preservative, labeled by Coherus Oncology, Inc. The packaging also includes a visual of the autoinjector device.*
FDA Label Image

Image Of Obi Carton Label (principal panel)

Image Of Obi Carton Label (principal panel)
Label for UDENYCA (pegfilgrastim-cbqv) Injection, 6 mg/0.6 mL, subcutaneous solution by Coherus Oncology, Inc. The label indicates a single-dose prefilled syringe and sterile on-body injector included. It specifies storage conditions, usage instructions, and components of the carton contents, with emphasis on the 6 mg/0.6 mL dose delivered by the prefilled syringe when used with the on-body injector.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.